NYSE:ALR - Alere Stock Price, News, & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Sign in or create an account to add this stock to your watchlist. Get Started $2.50 +0.02 (+0.81 %) (As of 03/20/2019 04:00 PM ET)Previous Close$2.48Today's Range$2.47 - $2.5052-Week Range$34.41 - $51.00Volume19,774 shsAverage Volume1.53 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options. Receive ALR News and Ratings via Email Sign-up to receive the latest news and ratings for ALR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryHealth Care Supplies SectorN/A Current SymbolNYSE:ALR Previous Symbol CUSIP01449J10 CIK1145460 Webwww.alere.com Phone+1-781-6473900Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Alere (NYSE:ALR) Frequently Asked Questions What is Alere's stock symbol? Alere trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALR." How were Alere's earnings last quarter? Alere Inc (NYSE:ALR) issued its quarterly earnings results on Friday, November, 4th. The medical research company reported $0.19 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.54 by $0.35. The medical research company earned $582 million during the quarter, compared to analysts' expectations of $605.50 million. Alere's revenue was down 3.6% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.10) earnings per share. View Alere's Earnings History. Has Alere been receiving favorable news coverage? News articles about ALR stock have trended positive on Wednesday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Alere earned a coverage optimism score of 2.3 on InfoTrie's scale. They also assigned headlines about the medical research company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the company's share price in the immediate future. Who are Alere's key executives? Alere's management team includes the folowing people: Gregg J. Powers, Independent Chairman of the BoardNamal Nawana, President, Chief Executive Officer, DirectorJames F. Hinrichs, Chief Financial Officer, Executive Vice PresidentDaniella Cramp, Global President - Cardiometabolic Business UnitSanjay Malkani, Global President - ToxicologyAvi Pelossof, Global President - Infectious Disease Business UnitEllen Chiniara J.D., Senior Vice President, General Counsel, Chief Ethics and Compliance Officer, SecretaryRobert Hargadon, Senior Vice President - Global Human ResourcesJohn Bridgen Ph.D., Senior Vice President - Business DevelopmentMark Gladwell, Senior Vice President - Global Operations What is Alere's stock price today? One share of ALR stock can currently be purchased for approximately $2.50. What is Alere's official website? The official website for Alere is http://www.alere.com. How can I contact Alere? Alere's mailing address is 51 Sawyer Rd Ste 200, WALTHAM, MA 02453-3448, United States. The medical research company can be reached via phone at +1-781-6473900. MarketBeat Community Rating for Alere (NYSE ALR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 358 (Vote Outperform)Underperform Votes: 381 (Vote Underperform)Total Votes: 739MarketBeat's community ratings are surveys of what our community members think about Alere and other stocks. Vote "Outperform" if you believe ALR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/20/2019 by MarketBeat.com StaffFeatured Article: What is Net Asset Value (NAV)?